Status:
COMPLETED
Rectal Cancer Survivorship: Impact of Low Anterior Resection Syndrome (LARS) on the Quality of Life
Lead Sponsor:
University Hospital, Ghent
Conditions:
Rectal Cancer
Low Anterior Resection Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Quality of life and risk factors for developing major LARS are explored. Therapeutic options were explored in the cohort experiencing major LARS
Detailed Description
Quality of life and risk factors for developing major LARS are explored using the EORTC QLQ C30. Therapeutic options were explored in the cohort experiencing major LARS
Eligibility Criteria
Inclusion
- low anterior resection for rectal cancer between 2006-2016
- Adults
Exclusion
- abdomino perineal resection
- patients who do not understand Dutch
Key Trial Info
Start Date :
March 17 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
187 Patients enrolled
Trial Details
Trial ID
NCT06059170
Start Date
March 17 2017
End Date
December 31 2018
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University hospital Ghent
Ghent, Oost-Vlaanderen, Belgium, 9000